Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-02-20
2007-02-20
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S133100
Reexamination Certificate
active
10824981
ABSTRACT:
The invention relates to a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.
REFERENCES:
patent: 2953132 (1960-09-01), Richter et al.
patent: 3066671 (1962-12-01), Cohen
patent: 3608550 (1971-09-01), Stawski
patent: 3904482 (1975-09-01), Mehl
patent: 4024857 (1977-05-01), Blecher et al.
patent: 4116066 (1978-09-01), Mehl et al.
patent: 4300404 (1981-11-01), Mehl et al.
patent: 5516515 (1996-05-01), Vellucci et al.
patent: 5880103 (1999-03-01), Urban et al.
patent: 5889151 (1999-03-01), Mogensen et al.
patent: 5919453 (1999-07-01), Benoit et al.
patent: 6475983 (2002-11-01), Eid et al.
patent: 6787634 (2004-09-01), Benoit et al.
patent: 0 369 877 (1995-05-01), None
patent: WO 92/18626 (1992-10-01), None
patent: WO 91/05862 (1991-05-01), None
patent: WO 91/09967 (1991-07-01), None
patent: WO 92/03538 (1992-03-01), None
Uze et al. Cell. 1990, 60:225-234.
Riechmann et al., “Reshaping Human Antibodies for Therapy”, Nature, vol. 332, pp. 323-327, Mar. 24, 1988.
Colamonichi et al., “Characterization of Three Monoclonal Antibodies that Recognize the Interactions of α-2 Receptor”, Proceedings of the National Academy of Sciences of the USA, vol. 87, No. 18, (Sep. 1990).
Langer et al., “Interferon Receptors”, Immunology Today, vol. 9, No. 12, pp. 393-400, (Dec. 1988).
Benoit et al., “A Monoclonal Antibody to Recombinant Human IFN-α, Receptor Inhibits Biologic Activity of Several Species of Human IFN-α, IFN-β, and IFN-ω1”, The Journal of Immunology, vol. 150, No. 3, pp. 707-716, (Feb. 1993).
Yonehara et al., “Monoclonal Anti-Idiotype Antibody for Anti-Human Interferon-αthat Complete with Interferon-α in Binding to Human Cell Surface and Inhibit the Interferon Action”, Elsevier Science Publication BV, pp. 167-171 (1986).
Waldmann, T., Science, vol. 252, pp. 1657-1662, (Jun. 1991).
Harris et al., TiBTECH, vol. 11, pp. 42-44, (Feb. 1993).
Langer et al., Immunology Today, vol. 9, No. 12, pp. 393-400, (1988).
Larrick et al., Bio Techniques, pp. 6-14, (Jan./Feb. 1984).
McGuinness et al., Mol. Microbiol. 7:505-514, 1993.
McGuinness et al., Lancet 337:514-517, 1993.
Orten et al., Biochemistry, 8thEdition, The C.V. Mosby Company, St. Louis, pp. 57-90, 1970.
Benoit Patrick
Maguire Deborah
Meyer Francois
Plavec Ivan
Tovey Michael G.
Chan Christina
Kim Yunsoo
Medarex Inc.
LandOfFree
Monoclonal antibodies against the interferon receptor, with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies against the interferon receptor, with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies against the interferon receptor, with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850689